Share this article:

The Oscars 2024 | From Barbie's Ken to Oppenheimer - what does this years' ceremony teach us about HR?

From Barbie's Ken to Oppenheimer - what does this years' ceremony teach us about HR?
From Barbie's Ken to Oppenheimer - what does this years' ceremony teach us about HR?

The Oscars 2024 was an event to behold.

Unsurprisingly, Christopher Nolan's epic atomic bomb movie Oppenheimer nabbed the most awards, whilst the most talked about performance wasn't from your usual pop star, but from Ryan Gosling as Barbie's Ken.

Beyond all the glitz and glamour, a few lessons can be learned about navigating the corporate world and people management...

We can learn from the past

Oscar frontrunners from this year Oppenheimer and Killers of the Flower Moon show us a moment in history, through the eyes of its directors. Oppenheimer is the story of the team of scientists who developed and designed the atomic bomb, whilst Killers of the Flower Moon tells the story of murders within the Osage Nation, a native American tribe.

Subscribe now to myGrapevine+ and get access to our comprehensive knowledge portal.


Already a subscriber?Sign in

Welcome Back

Sign up to our daily newsletter

Have content like this delivered directly to your inbox.


Recommended

HR Grapevine
HR Grapevine | Executive Grapevine International Ltd
  • News
  • 3 mins read

Comms controversy | Football club admits email to long-serving staff 'should have been handled better'

HR Grapevine
HR Grapevine | Executive Grapevine International Ltd
  • Opinion
  • 3 mins read

Absenteeism | MP's sick day admission is something HR shouldn't ignore

HR Grapevine
HR Grapevine | Executive Grapevine International Ltd
  • Column
  • 7 mins read

Failing forward | How HR can build a culture of experimentation

HR Grapevine
HR Grapevine | Executive Grapevine International Ltd
  • Webinar

The AI-Enabled Workforce: Building Compliant, High-Performing Distributed Teams in the AI Era

HR Grapevine
HR Grapevine | Executive Grapevine International Ltd
  • Resource
  • Download Report

The GLP-1 blind spot: why MSK must sit at the centre of every GLP-1 strategy